2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

Ashish Kumar Gupta,1 Gaurav Khunger Kumar,1 Komal Rani,1 Ruchika Pokhriyal,1 Mohd Imran Khan,1 Domada Ratna Kumar,1 Vinay Goyal,2 Manjari Tripathi,2 Rishab Gupta,3 Rakesh Kumar Chadda,3 Perumal Vanamail,4 Ashok Kumar Mohanty,5 Gururao Hariprasad1 1Department of Biophysics, All India Institute of Me...

Full description

Bibliographic Details
Main Authors: Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad G
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Parkinson’s disease
Schizophrenia
Gel based proteomics
biomarkers
dopamine
pharmacological efficacy
Difference Gel Electrophoresis
Online Access:https://www.dovepress.com/2d-dige-as-a-strategy-to-identify-serum-protein-biomarkers-to-monitor--peer-reviewed-article-NDT

Internet

https://www.dovepress.com/2d-dige-as-a-strategy-to-identify-serum-protein-biomarkers-to-monitor--peer-reviewed-article-NDT

Similar Items